Maimets T - Search Results

1

Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein.

Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel U. Johansson HJ, et al. Among authors: maimets t. Mol Ther. 2008 Jan;16(1):115-23. doi: 10.1038/sj.mt.6300346. Epub 2007 Nov 6. Mol Ther. 2008. PMID: 17984975 Free article.

2

Characterization of a Novel Cytotoxic Cell-penetrating Peptide Derived From p14ARF Protein.

Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel Ü. Johansson HJ, et al. Among authors: maimets t. Mol Ther. 2008 Jan;16(1):115-123. doi: 10.1038/sj.mt.6300346. Epub 2016 Dec 7. Mol Ther. 2008. PMID: 28192705

3

Pre-administration of PepFect6-microRNA-146a nanocomplexes inhibits inflammatory responses in keratinocytes and in a mouse model of irritant contact dermatitis.

Urgard E, Lorents A, Klaas M, Padari K, Viil J, Runnel T, Langel K, Kingo K, Tkaczyk E, Langel Ü, Maimets T, Jaks V, Pooga M, Rebane A. Urgard E, et al. Among authors: maimets t. J Control Release. 2016 Aug 10;235:195-204. doi: 10.1016/j.jconrel.2016.06.006. Epub 2016 Jun 3. J Control Release. 2016. PMID: 27269729

4

miR-10a-5p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation.

Vaher H, Runnel T, Urgard E, Aab A, Carreras Badosa G, Maslovskaja J, Abram K, Raam L, Kaldvee B, Annilo T, Tkaczyk ER, Maimets T, Akdis CA, Kingo K, Rebane A. Vaher H, et al. Among authors: maimets t. Allergy. 2019 Nov;74(11):2146-2156. doi: 10.1111/all.13849. Epub 2019 Jun 6. Allergy. 2019. PMID: 31049964 Free PMC article.

5

Targeted gene silencing in human embryonic stem cells using cell-penetrating peptide PepFect 14.

Ervin EH, Pook M, Teino I, Kasuk V, Trei A, Pooga M, Maimets T. Ervin EH, et al. Among authors: maimets t. Stem Cell Res Ther. 2019 Jan 24;10(1):43. doi: 10.1186/s13287-019-1144-x. Stem Cell Res Ther. 2019. PMID: 30678718 Free PMC article.

6

Use of PepFect14 and siRNA for Targeted Gene Silencing in Human Embryonic Stem Cells.

Ervin EH, Pooga M, Maimets T. Ervin EH, et al. Among authors: maimets t. Methods Mol Biol. 2022;2383:579-585. doi: 10.1007/978-1-0716-1752-6_37. Methods Mol Biol. 2022. PMID: 34766315

7

von Willebrand factor and transforming growth factor-beta modulate immune response against coagulation factor VIII in FVIII-deficient mice.

Kallas A, Kuuse S, Maimets T, Pooga M. Kallas A, et al. Among authors: maimets t. Thromb Res. 2007;120(6):911-9. doi: 10.1016/j.thromres.2007.02.002. Epub 2007 Mar 21. Thromb Res. 2007. PMID: 17376515

8

Von Willebrand factor-specific antibodies developing upon treatment of FVIII-deficient mice with different FVIII preparations.

Kallas A, Kuuse S, Maimets T, Pooga M. Kallas A, et al. Among authors: maimets t. Acta Haematol. 2008;119(4):244-7. doi: 10.1159/000142614. Epub 2008 Jul 2. Acta Haematol. 2008. PMID: 18594135 No abstract available.

9

Naturally occurring CD4+ CD25+ cells in modulating immune response to administered coagulation factor VIII in factor VIII-deficient mice.

Kallas A, Kuuse S, Maimets T, Pooga M. Kallas A, et al. Among authors: maimets t. Haemophilia. 2011 Jan;17(1):143-51. doi: 10.1111/j.1365-2516.2010.02376.x. Epub 2010 Aug 22. Haemophilia. 2011. PMID: 20731724

10

Changes in Laminin Expression Pattern during Early Differentiation of Human Embryonic Stem Cells.

Pook M, Teino I, Kallas A, Maimets T, Ingerpuu S, Jaks V. Pook M, et al. Among authors: maimets t. PLoS One. 2015 Sep 17;10(9):e0138346. doi: 10.1371/journal.pone.0138346. eCollection 2015. PLoS One. 2015. PMID: 26378917 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters